Kineta Completes Reverse Merger with Yumanity Therapeutics
Shares of Kineta to commence trading on Nasdaq under new ticker symbol “KA” on December 19, 2022 Seattle, WA — (December 19, 2022) Kineta, Inc. (“Kineta” or the “Company”), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address cancer immune resistance, announced today the completion of its reverse [...]
Recon Capital Team Joins Horizons ETFs Management (USA) LLC
BUSINESS WIRE Recon Capital Advisors, LLC (“RCA”), the investment adviser to the four exchange-traded funds that make up the Recon Capital Series Trust, has entered into an agreement to be acquired by Horizons ETFs Management (USA) LLC (“Horizons USA”), a member of the Horizons Exchange Traded Funds Group, one of [...]
Crunch Franchise Announces Its Newest Location In Huntingdon Valley, PA
PR Newswire NEW YORK, Nov. 1, 2016 NEW YORK, Nov. 1, 2016 /PRNewswire/ -- Crunch, the health club chain best known for making serious fitness fun through unique programming and cutting-edge training, announces the opening of its newest franchise location at 759 Huntingdon Pike, Huntingdon Valley, PA. The club opened [...]
Seattle biotech firm Kineta raises $1.6 million to boost its battle against disease
Kineta, a Seattle-based biotech startup, has raised an investment round worth almost $1.6 million from existing investors in the company. The investment will be used to fund continued development of the drugs that the company is working on. “This new raise comes from existing investors and shows confidence in what the [...]
Kineta, Inc. and RLB Holdings Announce New Joint Venture to Address High-Need Therapeutics Including Autoimmune Diseases
Kineta, Inc., a biotechnology company focused on the development of immune-modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture, Kineta RLB, LLC, which will commercialize promising, high-value compounds in selective disease areas with unmet medical needs. “The [...]
Kineta, Children’s join in pediatric clinical-trial effort
Seattle biotechnology company Kineta and Seattle Children’s Research Institute are joining in an effort to improve development and testing of therapies for pediatric autoimmune diseases. Their collaboration, called Alliance for Children’s Therapeutics, will be funded both by philanthropic gifts to the research institute and equity investments in Kineta. Its initial [...]
Seattle Children’s Research Institute and Kineta Launch the Alliance for Children’s Therapeutics
Seattle Children’s Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children’s Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, Type 1 diabetes and rheumatoid arthritis. “Funding for pediatric research [...]
Gary Bettman: NHL not considering expansion into Seattle now
NHL commissioner Gary Bettman slammed the brakes on any Seattle expansion plans Thursday, citing continued uncertainty over construction of a new arena. By Geoff Baker Seattle Times staff reporter NEW YORK — NHL commissioner Gary Bettman slammed the brakes on any Seattle expansion plans Thursday, citing continued uncertainty over construction of [...]